A recent trial revealed that two-thirds of adults with severe peanut allergies can be desensitized through oral immunotherapy, a method already effective in children. This comes amidst rising allergy prevalence, with UK food anaphylaxis admissions tripling between 1998 and 2018. The treatment, designed to combat the anxiety of accidental exposure, requires intensive clinical supervision and gradual dosing. Historical attempts date back to 1908, but advancements have made these treatments practical today. With options now available, experts hope to reduce the burden of allergies and improve the lives of those affected.
The surge of interest in treating allergies has been motivated, in part, by an unprecedented rise in prevalence, with food anaphylaxis admissions to UK hospitals increasing threefold between 1998 and 2018.
The first successful use of oral immunotherapy was reported in The Lancet in 1908, paving the way for current treatments that could potentially cure allergies.
Collection
[
|
...
]